BRIEF-Protalix Biotherapeutics' Pegunigalsidase Alfa Receives Fast Track Designation From FDA
1 分钟阅读
Jan 31 (Reuters) - Protalix Biotherapeutics Inc:
* PROTALIX BIOTHERAPEUTICS’ PEGUNIGALSIDASE ALFA RECEIVES FAST TRACK DESIGNATION FROM THE U.S. FOOD AND DRUG ADMINISTRATION Source text for Eikon: Further company coverage: